Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Melphalan × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Myelodysplastic Syndromes 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Multiple Myeloma 6 Hematologic Neoplasms 6 Neuroblastoma 4 Lymphoma 4 Leukemia, Biphenotypic, Acute 4 Leukemia 4 Hematologic Diseases 4 Myeloproliferative Disorders 3 Leukemia, B-Cell 3 Hodgkin Disease 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Recurrence 2 Primary Myelofibrosis 2 Preleukemia 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Neoplasms 2 Lymphoproliferative Disorders 2 Lymphoma, Mantle-Cell 2 Lymphatic Diseases 2 Leukemia, Myeloid 2 Leukemia, Lymphoid 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Immunoproliferative Disorders 2 Immune System Diseases 2

Interventions

X-Rays 3 Specimen Handling 3 Phantoms, Imaging 3 Nuclear Medicine Department, Hospital 3 Magnetic Resonance Spectroscopy 3 Biopsy 3 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 ulixertinib 1 tipifarnib 1 temsirolimus 1 tazemetostat 1 talazoparib 1 selpercatinib 1 palbociclib 1 olaparib 1 larotrectinib 1 irinotecan sucrosofate 1 Vincristine 1 Vemurafenib 1 Surgical Procedures, Operative 1 Sorafenib 1 Radiation 1 Proton Therapy 1 Liquid Biopsy 1 LY3023414 1 Ifosfamide 1 Etoposide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡